ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,646.88
1.04%
Dow Jones
44,931.11
0.49%
Gold vs US Dollar
2,792.82
1.18%
Brent Oil
75.885
-0.05%
Bitcoin
105,443.21
1.64%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. TransCode Therapeutics Inc (RNAZ) Share Price

RNAZ TransCode Therapeutics Inc

7.75
-0.65 (-7.74%)
Last Updated: 19:20:17
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 TransCode Therapeutics Inc NASDAQ:RNAZ NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.65 -7.74 7.75 7.75 7.88 9.40 7.44 8.4 534,684 19:20:17   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -18.55M -26.6376 -0.32 5.85M
 Type  Size  Price  Time  Units 
  100 7.75 19:20:17 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore RNAZ News
14/01/202513:00PRNUSTransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial
07/01/202513:00PRNUSNasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
30/12/202422:08EDGAR2Form DEF 14A - Other definitive proxy statements
20/12/202421:10EDGAR2Form 8-K - Current report
19/12/202421:48EDGAR2Form PRE 14A - Other preliminary proxy statements
18/12/202413:00PRNUSTransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial
18/12/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
Period
Draw mode
Data Downloads for RNAZ

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest TransCode Therapeutics Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads